Navellier & Associates Inc United Therapeutics Corp Transaction History

Navellier & Associates Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$174.81 - $241.14 $585,263 - $807,336	-3,348 Closed	0 $0
Q1 2022 Apr 29, 2022	SELL	$166.16 - $213.96 $6,147 - $7,916	-37 Reduced 1.09%	3,348 $601,000
Q4 2021 Feb 14, 2022	BUY	$184.32 - $216.08 $150,405 - $176,321	816 Added 31.76%	3,385 $731,000
Q3 2021 Oct 28, 2021	BUY	$179.86 - $214.88 $462,060 - $552,026	2,569 New	2,569 $474,000

671

42.3M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.4B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Navellier & Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Navellier & Associates Inc with notifications on news.